BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1478351)

  • 21. Insect cells as a new substrate for vaccine production.
    Dalemans W
    Dev Biol (Basel); 2006; 123():235-41; discussion 265-6. PubMed ID: 16566449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Presence of Mycoplasma in laboratory cell cultures from Cordoba, Argentina].
    Cumino AC; Córdoba P; Zapata TM
    Rev Argent Microbiol; 1998; 30(3):147-53. PubMed ID: 9793145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Internucleosomal DNA fragmentation in cultured cells under conditions reported to induce apoptosis may be caused by mycoplasma endonucleases.
    Paddenberg R; Wulf S; Weber A; Heimann P; Beck LA; Mannherz HG
    Eur J Cell Biol; 1996 Sep; 71(1):105-19. PubMed ID: 8884184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Susceptibility of various cell culture systems to bovine viral diarrhea virus.
    Ferrari M
    Microbiologica; 1985 Jan; 8(1):17-22. PubMed ID: 2983178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of substrata and fibroblast growth factor on the proliferation in vitro of bovine aortic endothelial cells.
    Gospodarowicz D; Lui GM
    J Cell Physiol; 1981 Oct; 109(1):69-81. PubMed ID: 6460040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spiroplasmas: infectious agents of plants, arthropods and vertebrates.
    Bové JM
    Wien Klin Wochenschr; 1997 Aug; 109(14-15):604-12. PubMed ID: 9286068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Susceptibility of the Sf9 insect cell line to infection with adventitious viruses.
    Zhang PF; Klutch M; Muller J; Marcus-Sekura CJ
    Biologicals; 1994 Sep; 22(3):205-13. PubMed ID: 7811453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of medium supplements on tick cells in culture.
    Kurtti TJ; Munderloh UG; Samish M
    J Parasitol; 1982 Oct; 68(5):930-5. PubMed ID: 7131199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strategy for adventitious agent assays.
    Robertson JS
    Dev Biol Stand; 1996; 88():37-40. PubMed ID: 9119160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Contamination of bovine fetal serum with bovine viral diarrhea virus].
    Zabal O; Kobrak AL; Lager IA; Schudel AA; Weber EL
    Rev Argent Microbiol; 2000; 32(1):27-32. PubMed ID: 10785940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Susceptibility of mouse minute virus to inactivation by heat in two cell culture media types.
    Schleh M; Romanowski P; Bhebe P; Zhang L; Chinniah S; Lawrence B; Bashiri H; Gaduh A; Rajurs V; Rasmussen B; Chuck A; Dehghani H
    Biotechnol Prog; 2009; 25(3):854-60. PubMed ID: 19405099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Production of influenza virus in serum-free mammalian cell cultures.
    Merten OW; Manuguerra JC; Hannoun C; van der Werf S
    Dev Biol Stand; 1999; 98():23-37; discussion 73-4. PubMed ID: 10494957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mycoplasmal contamination of cell cultures.
    Lundin DJ
    Am Biotechnol Lab; 1994 Jul; 12(8):42. PubMed ID: 7765012
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of automated culture systems with a CFR/USP-compliant method for sterility testing of cell-therapy products.
    Khuu HM; Stock F; McGann M; Carter CS; Atkins JW; Murray PR; Read EJ
    Cytotherapy; 2004; 6(3):183-95. PubMed ID: 15203975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methods for the detection of adventitious viruses in cell cultures used in the production of biotechnology products.
    Poiley JA
    Bioprocess Technol; 1990; 10():483-94. PubMed ID: 1367069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microbiological control in stem cell banks: approaches to standardisation.
    Cobo F; Stacey GN; Hunt C; Cabrera C; Nieto A; Montes R; Cortés JL; Catalina P; Barnie A; Concha A
    Appl Microbiol Biotechnol; 2005 Sep; 68(4):456-66. PubMed ID: 16012832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Viral risk mitigation for Mammalian cell culture media.
    Weaver B; Rosenthal S
    PDA J Pharm Sci Technol; 2010; 64(5):436-9. PubMed ID: 21502048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Best practices for detecting and mitigating the risk of cell culture contaminants.
    Nims RW; Price PJ
    In Vitro Cell Dev Biol Anim; 2017 Dec; 53(10):872-879. PubMed ID: 29197027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk Mitigation in Preventing Adventitious Agent Contamination of Mammalian Cell Cultures.
    Shiratori M; Kiss R
    Adv Biochem Eng Biotechnol; 2018; 165():75-93. PubMed ID: 29134459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. From bench to cageside: Risk assessment for rodent pathogen contamination of cells and biologics.
    Peterson NC
    ILAR J; 2008; 49(3):310-5. PubMed ID: 18506064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.